Evidence That ADCs Are Target Therapy: Sarat Chandarlapaty will address this topic in a Translational Controversies session at #SABCS25 (December 9-12). Learn more: https://t.co/yRfGG8LL1m

Happening Tuesday, 9/9 at #WCLC25: @MSKCancerCenter’s @JonesDavid2013 will discuss perioperative modalities for resectable non small cell #lungcancer. Follow along for coverage of the latest advances. #LCSM #SCLC @IASLC Tuesday, 9/9 | 1 p.m. CEST Learn more:

At #WCLC25, our @MSK_RadOnc colleague @JenniferMaMD will present a retrospective review of intrathoracic radiotherapy to treat #HPV-associated head and neck #squamouscellcarcinoma metastases. #LCSM @IASLC @MSKCancerCenter September 9 | 3 p.m. CEST ➡️ https://t.co/LcPtZuW5tk

Happening Tuesday, 9/9 at #WCLC25: @MSKCancerCenter’s @AlexisChidi will discuss how deep learning-based CT analysis enhances #lungcancer risk prediction in never smoking women. Follow along for coverage of the latest advances. #LCSM #SCLC @IASLC Tuesday, 9/9 | 10 a.m. CEST

Congrats to Matthew McMillan @MSKCancerCenter @MSK_RadOnc #WCLC25 on presenting the secondary analysis of #CURB trial, highlighting the importance of tumor volume burden in prognosis. @xrtGenomics

The @GSKGradSchool at MSK is now accepting applications for its Cancer Biology and Cancer Engineering programs for the 2026 academic year. Apply here: https://t.co/1nGY4mJXZ5.

Tomorrow morning, #lungcancer expert Mark Kris will discuss clinicopathologic features of TP53/RB1-mutant squamous cell lung cancer at #WCLC25. #LCSM @IASLC @MSKCancerCenter September 8 | 10:30 a.m.. CEST ➡️ https://t.co/DJNYmL4bFb

#SOHO2025: Roni Shouval, MD, PhD (@RShouval), director of the Precision Cellular Therapy Laboratory at New York’s @MSKCancerCenter. Dr. Shouval spoke Sept. 6, 2025, at @SocietyofHemOnc in Houston. #RareDisease #Hematology #Oncology

Dr Helena Yu #WCLC: leptomeningeal disease (LMD) in #lungcancer is tough to diagnose, yet early diagnosis is key. Peole w LMD are living longer but better tools & trials are urgently needed: CNS cohorts, imaging, risk-adaptive RT & new genomic methods to understand spread. @MSKCC

Coming up at #WCLC25: @MSKCancerCenter's @HelenaYu923 will highlight diagnostic and treatment opportunities for #leptomeningealdisease in oncogene-driven non-small cell #lungcancer. #LCSM @IASLC September 7 | 3:53 p.m. CEST ➡️ https://t.co/NiWF2LPpeO

Don't miss an opportunity to learn from the Chief of the Thoracic Oncology Service at @MSKCancerCenter! At #WCLC25, @DrMarkAwad will share lessons about work-life balance in high-stress medical careers. #LCSM @IASLC September 7 | 1:45 p.m. CEST ➡️ https://t.co/L9me3u38xx

Loved hearing Dr. Lorenzo Falchi from @MSKCancerCenter share exciting updates on immunotherapy in IBCL, followed by a really inspiring lunch talk about his career journey and advice for junior YIP awardees at SOHO2025. @SocietyofHemOnc #SOHO2025

Happening Monday, 9/8 at #WCLC25: MSK's @natasharekhtman will discuss optimizing front-line treatment for small cell #lungcancer. Follow along for coverage of the latest advances. #LCSM #SCLC @IASLC Learn more: https://t.co/zLyrjg8VfN 📅 September 8 at 5 p.m. CEST

Happening tomorrow at #WCLC25: @MSKCancerCenter’s @charlesrudin will highlight future directions in small cell #lungcancer research. Follow along for coverage of the latest advances. #LCSM #SCLC @IASLC September 6 | 10:30 a.m. CEST ➡️ https://t.co/Ms6YwmS33Q

✨ As part of #ClinicalNurseSpecialistsWeek, we celebrated the heart, expertise, and leadership that our CNSs bring to MSK every day with a group breakfast, luncheon, and a @NACNS webinar. From coffee to connection, it's been a wonderful few days full of gratitude and good vibes.

Excited to share new @BCD_AACR paper where we show how BCMA mutations driving BsAb resistance are acquired during therapy. Another exciting study from our great collaboration with Paola Neri @NBahlis @RascheLeo! @MSKCancerCenter @MSK_DeptOfMed @SylvesterCancer @UCalgary #mmsm

Synapse: Your Connection to our MSK Authors Meet: Corita Reilley Grudzen Research Focus: Medicine; Div Head Attending Effect of a multi-component palliative care intervention on goals of care discussions for critical patients in the emergency department https://t.co/NAOfqrZSpo

Late-breaking abstract submission is now open for the San Antonio Breast Cancer Symposium, December 9-12, 2025. Abstract deadline: September 30. Learn more: https://t.co/or7QYb84Qb #SABCS25

At MSK, Clinical Nurse Specialists (CNS) are making a significant impact on patient outcomes through their expert guidance, evidence-based interventions, and compassionate leadership. Their contributions are felt across all units and in every life they touch. This #CNSWeek, we

Results of a pilot study led by investigators at @MSKCancerCenter showed that interleukin-18 “armored” CAR T cells targeting CD371 were effective at treating relapsed/refractory acute myeloid #leukemia at low doses. @BloodPortfolio @DaniyanMd @AbdelWahablab Learn more: